Cargando…

Metabolic Reprogramming of Glioblastoma Cells during HCMV Infection Induces Secretome-Mediated Paracrine Effects in the Microenvironment

Glioblastoma (GBM) is an aggressive primary central nervous system neoplasia with limited therapeutic options and poor prognosis. Following reports of cytomegalovirus (HCMV) in GBM tumors, the anti-viral drug Valganciclovir was administered and found to significantly increase the longevity of GBM pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Harrison, Mark A. A., Hochreiner, Emily M., Benjamin, Brooke P., Lawler, Sean E., Zwezdaryk, Kevin J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777757/ https://www.ncbi.nlm.nih.gov/pubmed/35062307 http://dx.doi.org/10.3390/v14010103

Ejemplares similares

Glioblastoma Stem Cells Microenvironment: The Paracrine Roles of the Niche in Drug and Radioresistance
por: Fidoamore, Alessia, et al.
Publicado: (2016)

HCMV Reprogramming of Infected Monocyte Survival and Differentiation: A Goldilocks Phenomenon
por: Stevenson, Emily V., et al.
Publicado: (2014)

Glioblastoma microenvironment and its reprogramming by oncolytic virotherapy
por: Qi, Zhongbing, et al.
Publicado: (2022)

Embryonic protein NODAL regulates the breast tumor microenvironment by reprogramming cancer-derived secretomes
por: Dieters-Castator, Dylan, et al.
Publicado: (2021)

CD97 is associated with mitogenic pathway activation, metabolic reprogramming, and immune microenvironment changes in glioblastoma
por: Safaee, Michael M., et al.
Publicado: (2022)

Metabolic reprogramming of the ovarian cancer microenvironment in the development of antiangiogenic resistance: Metabolic reprogramming of the OC microenvironment
por: Yue, Huiran, et al.
Publicado: (2023)

The cancer cell secretome drives cooperative manipulation of the tumour microenvironment to accelerate tumourigenesis
por: Ritchie, Shona, et al.
Publicado: (2021)

Sustained neuronal viability by paracrine factors: new opportunities for endothelial progenitor cell secretome
por: Di Santo, Stefano, et al.
Publicado: (2020)

Empagliflozin Suppresses the Differentiation/Maturation of Human Epicardial Preadipocytes and Improves Paracrine Secretome Profile
por: Takano, Masayuki, et al.
Publicado: (2023)

Exosomal cargos-mediated metabolic reprogramming in tumor microenvironment
por: Tan, Shiming, et al.
Publicado: (2023)

Macrophages and Metabolic Reprograming in the Tumor Microenvironment
por: Liu, Jin, et al.
Publicado: (2022)

Understanding metabolic reprogramming in tumor microenvironment
por: Shu, Shaokun, et al.
Publicado: (2022)

Role of extracellular matrix and microenvironment in regulation of tumor growth and LAR-mediated invasion in glioblastoma
por: Kim, Yangjin, et al.
Publicado: (2018)

HCMV glycoprotein B is expressed in primary glioblastomas and enhances growth and invasiveness via PDGFR-alpha activation
por: Cobbs, Charles, et al.
Publicado: (2014)

Paracrine activin B-NF-κB signaling shapes an inflammatory tumor microenvironment in gastric cancer via fibroblast reprogramming
por: Jin, Yangbing, et al.
Publicado: (2023)

HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

Thyroid Transcription Factor 1 Reprograms Angiogenic Activities of Secretome
por: Wood, Lauren W., et al.
Publicado: (2016)

Therapeutic Drug-Induced Metabolic Reprogramming in Glioblastoma
por: Nguyen, Trang T. T., et al.
Publicado: (2022)

Development and Characterization of an HCMV Multi-Antigen Therapeutic Vaccine for Glioblastoma Using the UNITE Platform
por: Adhikari, Amit S., et al.
Publicado: (2022)

EphA2 is a functional entry receptor for HCMV infection of glioblastoma cells
por: Dong, Xiao-Dong, et al.
Publicado: (2023)

Metabolic reprogramming in tumors: Contributions of the tumor microenvironment
por: Lane, Andrew N., et al.
Publicado: (2019)

The role of lipid metabolic reprogramming in tumor microenvironment
por: Yang, Kai, et al.
Publicado: (2023)

US28: HCMV’s Swiss Army Knife
por: Krishna, Benjamin A., et al.
Publicado: (2018)

CXCL6 is an important paracrine factor in the pro-angiogenic human cardiac progenitor-like cell secretome
por: Torán, José Luis, et al.
Publicado: (2017)

Supporting data on in vitro cardioprotective and proliferative paracrine effects by the human amniotic fluid stem cell secretome
por: Balbi, Carolina, et al.
Publicado: (2019)

Secretome analysis of breast cancer-associated adipose tissue to identify paracrine regulators of breast cancer growth
por: Lore, Lapeire, et al.
Publicado: (2017)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
por: da Cunha, Bianca Rodrigues, et al.
Publicado: (2019)

Adipose-Derived Stem Cells from Obese Donors Polarize Macrophages and Microglia toward a Pro-Inflammatory Phenotype
por: Harrison, Mark A. A., et al.
Publicado: (2020)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Defining the Cardiac Fibroblast Secretome in a Fibrotic Microenvironment
por: Ceccato, Tova L., et al.
Publicado: (2020)

Inflammatory Breast Cancer: The Secretome of HCMV(+) Tumor-Associated Macrophages Enhances Proliferation, Invasion, Colony Formation, and Expression of Cancer Stem Cell Markers
por: Mohamed, Hossam Taha, et al.
Publicado: (2022)

Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)

Metabolic management of microenvironment acidity in glioblastoma
por: Seyfried, Thomas N., et al.
Publicado: (2022)

Metabolic reprogramming by miRNAs in the tumor microenvironment: Focused on immunometabolism
por: Alshahrani, Shadia Hamoud, et al.
Publicado: (2022)

Editorial: Metabolic reprogramming for acquiring therapeutic resistance in glioblastoma
por: Hsu, Tsung-I
Publicado: (2023)

Abstract 2028: Protein O-GlcNAcylation modulates the secretome of keratinocyte and its paracrine regulation of fibroblast function
por: Wang, Yan, et al.
Publicado: (2023)

A MYCN-independent mechanism mediating secretome reprogramming and metastasis in MYCN-amplified neuroblastoma
por: Zhang, Hai-Feng, et al.
Publicado: (2023)

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
por: Gouirand, Victoire, et al.
Publicado: (2018)

Metabolic Reprogramming in the Tumor Microenvironment With Immunocytes and Immune Checkpoints
por: Xu, Yaolin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4fl95fgn9fhl2tikh57207eu82